Browse the 2024 Event Guide to Discover What You Missed Out:

18+ world-class biopharma expert speakers from Bayer, Boehringer Ingelheim, Genentech, Novartis and more

Interactive roundtable discussion reviewing global regulatory guidelines for retinal vascular drug development to determine disease-specific endpoints and manifestations, for improved clinical trial design for a larger patient population

7+ hours of dedicated networking and a scientific poster session to share your recent research developing novel therapeutic treatment for retinal neovascularization, retinal imaging techniques and more, with the community in a casual setting

Data-driven and discussion-based Pre-Conference Workshop Day discussing preclinical in vivo models, anti-VEGF non-responders and improved retinal delivery methods to improve patient compliance


Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Previously Attending Companies Include:

“The event was so enjoyable, will continue to follow the upcoming events in same field” 

Senior Principal Scientist, Merck & Co